Kasprzak, Julia
Westphalen, C. Benedikt
Frey, Simon
Schmitt, Yvonne
Heinemann, Volker
Fey, Theres
Nasseh, Daniel
Funding for this research was provided by:
Roche Pharma AG
Universitätsklinik München
Article History
Received: 24 July 2023
Accepted: 21 March 2024
First Online: 10 April 2024
Declarations
:
: Simon Frey and Yvonne Schmitt are employees of Roche Pharma AG. Christoph Benedikt Westphalen (CBW) has received honoraria from Amgen, Bayer, BMS, Chugai, Celgene, Falk, GSK, MSD, Merck, Janssen, Ipsen, Roche, Servier, SIRTeX, Taiho. CBW served on advisory boards for Bayer, BMS, Celgene, Janssen, MSD, Servier, Shire/Baxalta, Rafael Pharmaceuticals, RedHill, Roche. CBW has received travel support by Bayer, Celgene, Janssen, RedHill, Roche, Servier, Taiho and research grants (institutional) by Roche. CBW serves as an officer for European Society of Medical Oncology (ESMO), Deutsche Krebshilfe (DKH), Arbeitsgemeinschaft internistische Onkologie (AIO). CBW is a member of the EU Commission expert group: Mission Board for cancer. Volker Heinemann (VH) has received honoraria from Amgen, Astra-Zeneca, Merck, Pfizer, Pierre-Fabre, Roche, Sanofi, SIRTEX, Servier. VH served on advisory boards for Amgen, Boehringer Ingelheim, BMS, Celgene, Merck, MSD, Novartis, Pierre-Fabre, Roche, Sanofi, SIRTEX, Servier, Terumo. VH has received travel support by Amgen, Bayer, Merck, Roche, SIRTEX, Servier and research grants (institutional) by Amgen, Bayer, Boehringer-Ingelheim, Merck, Pfizer, Roche, Sanofi, Sirtex, Servier.
: Not applicable.
: Not applicable.
: Not applicable.